160 related articles for article (PubMed ID: 27381449)
1. Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9.
Feng J; Jing J; Sanchez-Lara PA; Bootwalla MS; Buckley J; Wu N; Yan Y; Chai Y
Genesis; 2016 Sep; 54(9):490-6. PubMed ID: 27381449
[TBL] [Abstract][Full Text] [Related]
2. Generation of tamoxifen-inducible Tfap2b-CreER
Zhang M; Feng J; Li Y; Qin PZ; Chai Y
Genesis; 2024 Feb; 62(1):e23582. PubMed ID: 38069547
[TBL] [Abstract][Full Text] [Related]
3. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
4. Targeted knock-in of CreER
Kesavan G; Hammer J; Hans S; Brand M
Cell Tissue Res; 2018 Apr; 372(1):41-50. PubMed ID: 29435650
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development.
Nakahara R; Kawai Y; Oda A; Nishimura M; Murakami A; Azuma T; Kaifu T; Goitsuka R
Genesis; 2014 Nov; 52(11):916-23. PubMed ID: 25283275
[TBL] [Abstract][Full Text] [Related]
6. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S
Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a tamoxifen-inducible Vsx1-CreER
Baudouin C; Pelosi B; Courtoy GE; Achouri Y; Clotman F
Genesis; 2021 Aug; 59(7-8):e23435. PubMed ID: 34080769
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line.
Pimeisl IM; Tanriver Y; Daza RA; Vauti F; Hevner RF; Arnold HH; Arnold SJ
Genesis; 2013 Oct; 51(10):725-33. PubMed ID: 23897762
[TBL] [Abstract][Full Text] [Related]
9. Generation of Nkx2-5/CreER transgenic mice for inducible Cre expression in developing hearts.
Ranjbarvaziri S; Park S; Nguyen NB; Gilmore WB; Zhao P; Ardehali R
Genesis; 2017 Aug; 55(8):. PubMed ID: 28589709
[TBL] [Abstract][Full Text] [Related]
10. Characterizing a novel vGlut3-P2A-iCreER knockin mouse strain in cochlea.
Li C; Shu Y; Wang G; Zhang H; Lu Y; Li X; Li G; Song L; Liu Z
Hear Res; 2018 Jul; 364():12-24. PubMed ID: 29706463
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a tamoxifen inducible Msx1(CreERT2) knock-in allele.
Lallemand Y; Moreau J; Cloment CS; Vives FL; Robert B
Genesis; 2013 Feb; 51(2):110-9. PubMed ID: 23090744
[TBL] [Abstract][Full Text] [Related]
12. An inducible Cldn11-CreER
Ortsäter H; Hernández-Vásquez MN; Ulvmar MH; Gow A; Mäkinen T
Genesis; 2021 Aug; 59(7-8):e23439. PubMed ID: 34338433
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER
Mayr D; Preishuber-Pflügl J; Koller A; Brunner SM; Runge C; Ladek AM; Rivera FJ; Reitsamer HA; Trost A
Curr Eye Res; 2022 Apr; 47(4):590-596. PubMed ID: 34758271
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines.
Stone JS; Wisner SR; Bucks SA; Mellado Lagarde MM; Cox BC
J Assoc Res Otolaryngol; 2018 Aug; 19(4):381-399. PubMed ID: 29869046
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a unique cell population marked by transgene expression in the adult cochlea of nestin-CreER(T2)/tdTomato-reporter mice.
Chow CL; Guo W; Trivedi P; Zhao X; Gubbels SP
J Comp Neurol; 2015 Jul; 523(10):1474-87. PubMed ID: 25611038
[TBL] [Abstract][Full Text] [Related]
17. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis.
Zhang L; Zhang B; Han SJ; Shore AN; Rosen JM; Demayo FJ; Xin L
Transgenic Res; 2012 Oct; 21(5):1117-23. PubMed ID: 22350718
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis.
Bhol CS; Patil S; Sahu BB; Patra SK; Bhutia SK
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188561. PubMed ID: 33965511
[TBL] [Abstract][Full Text] [Related]
19. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
20. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities.
Peters H; Neubüser A; Kratochwil K; Balling R
Genes Dev; 1998 Sep; 12(17):2735-47. PubMed ID: 9732271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
